Palatin Technologies
PTN
#9923
Rank
NZ$67.78 M
Marketcap
NZ$39.81
Share price
4.59%
Change (1 day)
2,418.16%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$28.79 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$46.63 Million, an increase over its 2023 earnings that were of -NZ$56.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$28.79 Million-38.28%
2024 -NZ$46.63 Million-16.9%
2023 -NZ$56.12 Million5.99%
2022 -NZ$52.95 Million-13.7%
2021 -NZ$61.35 Million33.25%
2020 -NZ$46.04 Million-172.11%
2019 NZ$63.84 M2352.33%
2018 NZ$2.6 M-94.13%
2017 NZ$44.36 M-154.92%
2016 -NZ$80.78 Million3.67%
2015 -NZ$77.92 Million878%
2014 -NZ$7.97 Million-72.64%
2013 -NZ$29.12 Million-33.11%
2012 -NZ$43.53 Million77.71%
2011 -NZ$24.5 Million
2003 -NZ$41.48 Million29.93%
2002 -NZ$31.93 Million36.18%
2001 -NZ$23.45 Million
1999 -NZ$19.46 Million6.04%
1998 -NZ$18.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-NZ$20.44 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$51.04 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$87.5 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$96.16 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.65 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK